Current and Emerging Treatments

Watch this video to learn about medications used in the treatment of Crohn's disease and ulcerative colitis, including 5-ASAs, immunosuppressants, steroids, biologics, biosimilars, and other emerging treatments for IBD in Canada. Find out from an expert gastroenterologist how these medications work in IBD, what they are used for, which types of patients can access these medications, potential benefits, side effects, and risks. Other topics include minimizing steroid use, discussing treatment goals with healthcare providers, and the role of treatment in promoting mucosal (gut) healing. 


Dr. John K. Marshall (MD, MSc, FRCPC, CAGF, AGAF), Professor of Medicine, Director, Division of Gastroenterology, McMaster University


  • Canada has among the highest incidence rates of Crohn's and colitis in the world.
  • 1 in 140 Canadians lives with Crohn’s or colitis.
  • Families new to Canada are developing these diseases for the first time.
  • Incidence of Crohn’s in Canadian kids under 10 has doubled since 1995.
  • People are most commonly diagnosed before age 30.

Other Areas of Interest